How long till the end?

Quote
Anonymous said:
Good try Glaxo trolls New indication coming in 8 months that will treat a third of adult Americans. Growing 18-20% a month doesn't sound like the end is near to me. Have a great day :)
Click to expand...

A third of adult Americans? You live in fantasy land. They will milk you of your money and spit in your face for trying to play along. Class A bag holders like this will forever be sold dreams, without a hope of ever realizing them. You fail to understand the game. This thing is run by people who lap you mentally and financially.

The financial understanding of the average Amarin investor is pathetic. No wonder they're rigging this one.
 






We now know why a large pharma company did not buy out Amarin. They did their work and figured out that it would be a tough product to sell. We now see confirmation as the launch sales stink.
 






























Anonymous said:
The dirty secret is that the Amarin sales team is kicking ass and taking names, and that Q1'13 Vascepa sales have exceeded forecast. Watch for sales force expansion to happen soon to prep for ANCHOR launch to PCP's.
Click to expand...

Best part of this story has to be the overconfident bulls getting smacked around over and over; learning NOTHING in the process. "Fool me once... fool me ten times... fool me a thousand times..."
 






Anonymous said:
The dirty secret is that the Amarin sales team is kicking ass and taking names, and that Q1'13 Vascepa sales have exceeded forecast. Watch for sales force expansion to happen soon to prep for ANCHOR launch to PCP's.
Click to expand...

Joe Z keeping telling the sales force that line! We know you've been cashing out and just hoping to get fired so you get that 34 million severance.
Fat lady is singing Joe!
 






Market is up to new highs and this thing has crumbled about 50% in that same period. How do you think this POS will perform when we start dealing with the severe macro-economic problems? Figure it out.
 


















LOL Anybody looking for a herd of brainless retail investors? Look no further.

Once this one goes kaput, I'm sure some hedge fund will scoop you all up with a flurry of articles on some other 10 year old, dead-money biotech "exploring a buyout" with a cutting edge rehash of some existing product.

Please, continue to defend this stock passionately. They will continue to short with that same passion.
 






























I agree, is this a GSK rep whose lunch we are eating?

Sucks to be you, your market share tastes good for breakfast, lunch and dinner! What you gonna do when the Vascepa tank runs over you!
 






Anonymous said:
I agree, is this a GSK rep whose lunch we are eating?

Sucks to be you, your market share tastes good for breakfast, lunch and dinner! What you gonna do when the Vascepa tank runs over you!
Click to expand...

I wish these stock pumpers would leave the board. Right now, the launch does not look good and the stock price reflects that. In fact, if we were to use your analogy, the sales are so low, the Amarin reps will need the GSK reps to buy them lunch, because they can't afford it.
 






Anonymous said:
I agree, is this a GSK rep whose lunch we are eating?

Sucks to be you, your market share tastes good for breakfast, lunch and dinner! What you gonna do when the Vascepa tank runs over you!
Click to expand...

Did you sell enough fish sticks to pay the interest on your loan yet? No? Well get cracking or Pharmakon is gonna repossess the entire set up.
 






Future penny stock. Haha, they want to increase the borrowing limit. They're gonna take out another fat loan on retail's dime. Dilution coming on the conference call? I wouldn't be surprised.

Company consistently pisses on shareholders, who just smile and thank management as they take it. All management has to do is dangle the "buyout" carrot above retail's head. Funds sell options, management sells shares, retail happily welcomes financial robbery and everyone is satisfied: Nash equilibrium!
 






Top Bottom
Back
Quote